(Q40437469)

20 September 2017

title

FDG-PET/CT-guided intensity modulated head and neck radiotherapy: a pilot investigation (English)

1 reference

Adaptive radiation therapy

20 September 2017

main subject

0 references

Juergen Meyer

12

0 references

Bevan Yueh

object named as

Bevan Yueh

4

0 references

Paul E. Kinahan

object named as

Paul Kinahan

11

0 references

author name string

David L Schwartz

1

1 reference

20 September 2017

Eric C Ford

2

1 reference

20 September 2017

Joseph Rajendran

3

1 reference

20 September 2017

Marc D Coltrera

5

1 reference

20 September 2017

Jeffery Virgin

6

1 reference

20 September 2017

Yoshimi Anzai

7

1 reference

20 September 2017

David Haynor

8

1 reference

20 September 2017

Barbara Lewellen

9

1 reference

20 September 2017

David Mattes

10

1 reference

20 September 2017

Mark Phillips

13

1 reference

20 September 2017

Michael Leblanc

14

1 reference

20 September 2017

Kenneth Krohn

15

1 reference

20 September 2017

Janet Eary

16

1 reference

20 September 2017

George E Laramore

17

1 reference

20 September 2017

publication date

1 June 2005

1 reference

20 September 2017

1 reference

20 September 2017

volume

27

1 reference

20 September 2017

issue

6

1 reference

20 September 2017

page(s)

478-487

1 reference

Intensity modulated radiation therapy: a clinical review

20 September 2017

cites work

1 reference

A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9

21 January 2018

1 reference

7 January 2021

Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma

1 reference

7 January 2021

Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099

1 reference

7 January 2021

Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer

1 reference

7 January 2021

Hyperfractionated radiation therapy with or without concurrent low-dose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck: a prospective randomized trial

1 reference

7 January 2021

Quality of life in patients treated for head and neck cancer: a follow-up study 7 to 11 years after radiotherapy.

1 reference

7 January 2021

Quality of life outcomes after primary radiotherapy for squamous cell carcinoma of the base of tongue

1 reference

7 January 2021

The potential for sparing of parotids and escalation of biologically effective dose with intensity-modulated radiation treatments of head and neck cancers: a treatment design study

1 reference

7 January 2021

Intensity-modulated radiation therapy for head-and-neck cancer: the UCSF experience focusing on target volume delineation

1 reference

7 January 2021

Dose escalation with 3D conformal treatment: five year outcomes, treatment optimization, and future directions.

1 reference

7 January 2021

Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer.

1 reference

7 January 2021

Computed tomography of the clinically negative neck

1 reference

7 January 2021

Improving diagnostic accuracy of cervical metastases with computed tomography and magnetic resonance imaging

1 reference

7 January 2021

Computed tomography and magnetic resonance imaging of cervical metastasis

1 reference

7 January 2021

Selection and delineation of lymph node target volumes in head and neck conformal radiotherapy. Proposal for standardizing terminology and procedure based on the surgical experience

1 reference

7 January 2021

Extracranial head and neck: PET imaging with 2-[F-18]fluoro-2-deoxy-D-glucose and MR imaging correlation

1 reference

7 January 2021

A comparative diagnostic study of head and neck nodal metastases using positron emission tomography

1 reference

7 January 2021

Positron emission tomography of patients with head and neck carcinoma before and after high dose irradiation

1 reference

7 January 2021

Use of positron emission tomography with fluorodeoxyglucose in patients with extracranial head and neck cancers

1 reference

7 January 2021

Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography

1 reference

7 January 2021

Whole-body dual-modality PET/CT and whole-body MRI for tumor staging in oncology

1 reference

7 January 2021

FDG-PET/CT imaging for preradiotherapy staging of head-and-neck squamous cell carcinoma

1 reference

7 January 2021

Staging of head and neck squamous cell cancer with extended-field FDG-PET.

1 reference

7 January 2021

PET-CT image registration in the chest using free-form deformations

1 reference

7 January 2021

Determination and delineation of nodal target volumes for head-and-neck cancer based on patterns of failure in patients receiving definitive and postoperative IMRT.

1 reference

7 January 2021

Patterns of failure in patients receiving definitive and postoperative IMRT for head-and-neck cancer.

1 reference

7 January 2021

Patterns of local-regional recurrence following parotid-sparing conformal and segmental intensity-modulated radiotherapy for head and neck cancer

1 reference

7 January 2021

Where exactly does failure occur after radiation in head and neck cancer?

1 reference

7 January 2021

Treatment planning guidelines regarding the use of CT/PET-guided IMRT for cervical carcinoma with positive paraaortic lymph nodes

1 reference

7 January 2021

Potential for reduced toxicity and dose escalation in the treatment of inoperable non–small-cell lung cancer: A comparison of intensity-modulated radiation therapy (IMRT), 3D conformal radiation, and elective nodal irradiation

1 reference

7 January 2021

Image fusion between 18FDG-PET and MRI/CT for radiotherapy planning of oropharyngeal and nasopharyngeal carcinomas.

1 reference

7 January 2021

The impact of (18)FDG-PET on target and critical organs in CT-based treatment planning of patients with poorly defined non-small-cell lung carcinoma: a prospective study

1 reference

7 January 2021

Positron emission tomography using [18F]fluorodeoxyglucose (FDG-PET) in the clinically negative neck: is it likely to be superior?

1 reference

7 January 2021

18FDG-PET for the assessment of primary head and neck tumors: clinical, computed tomography, and histopathological correlation in 38 patients

1 reference

7 January 2021

FDG-PET. A possible prognostic factor in head and neck cancer

1 reference

7 January 2021

Identifiers

DOI

10.1002/HED.20177

1 reference

20 September 2017

1 reference